Literature DB >> 18251719

Relaxation induced by red wine polyphenolic compounds in rat pulmonary arteries: lack of inhibition by NO-synthase inhibitor.

Véronique Leblais1, Stéphanie Krisa, Josep Valls, Arnaud Courtois, Sabrina Abdelouhab, Alicia Martin Vila, Jean-Michel Mérillon, Bernard Muller.   

Abstract

Some red wine polyphenols exert nitric oxide (NO)-dependent relaxation in systemic arteries, following activation of endothelial NO synthase (eNOS). In this study, the effect of red wine polyphenols was determined in rat intrapulmonary arteries, and the effect of some of these compounds was compared with the responses obtained in rat aorta. In pulmonary arteries, red wine polyphenolic extract (> 300 microg/mL) exerted relaxation that was not inhibited by the NOS inhibitor N(omega)-nitro-L-arginine methylester (L-NAME) or endothelium removal. Among the several fractions obtained from the extract, the one enriched with anthocyanins was less active than fractions containing non-anthocyanins. Among the latter, the most active for relaxing pulmonary arteries was the one enriched in the stilbene derivative trans-resveratrol (relaxation for concentration >10 microg/mL). Trans-piceid, the glucoside derivative of trans-resveratrol, was almost inactive. Trans-resveratrol-induced relaxation, as well as relaxation to the anthocyanin delphinidin, was L-NAME-insensitive in pulmonary arteries. In aorta, trans-resveratrol and trans-piceid exerted similar effects to those in pulmonary arteries that were also not inhibited by L-NAME. However, red wine polyphenolic extract and delphinidin induced relaxation of aorta at much lower concentrations (about 10 microg/mL) than in pulmonary arteries, and their effects were inhibited by L-NAME. These data show differences between small intrapulmonary arteries and systemic conductance arteries in their responses to red wine polyphenols, the major difference being that the relaxant effect of these compounds is not blunted by NOS inhibitor in pulmonary arteries. They suggest that red wine polyphenols act directly on smooth muscle to promote pulmonary artery relaxation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18251719     DOI: 10.1111/j.1472-8206.2007.00546.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  4 in total

1.  Resveratrol Increases Serum BDNF Concentrations and Reduces Vascular Smooth Muscle Cells Contractility via a NOS-3-Independent Mechanism.

Authors:  Michał Wiciński; Bartosz Malinowski; Mateusz M Węclewicz; Elżbieta Grześk; Grzegorz Grześk
Journal:  Biomed Res Int       Date:  2017-02-05       Impact factor: 3.411

2.  Resveratrol did not alter blood pressure in rats with nitric oxide synthase-inhibited hypertension.

Authors:  Mehmet Aydin; Buket Gungor; A Secil Akdur; Hakki Engin Aksulu; Coskun Silan; Ibrahim Susam; Ali Kemal Cabuk; Gizem Cabuk
Journal:  Cardiovasc J Afr       Date:  2017 May/Jun       Impact factor: 1.167

Review 3.  Beneficial Effects of Resveratrol Administration-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions.

Authors:  Michał Wiciński; Maciej Socha; Maciej Walczak; Eryk Wódkiewicz; Bartosz Malinowski; Sebastian Rewerski; Karol Górski; Katarzyna Pawlak-Osińska
Journal:  Nutrients       Date:  2018-11-21       Impact factor: 5.717

4.  A novel evaluation of endothelial dysfunction ex vivo: "Teaching an Old Drug a New Trick".

Authors:  Lexiao Jin; Daniel J Conklin
Journal:  Physiol Rep       Date:  2021-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.